| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Nano Dimension Ltd.
13D/A
NNDM · 63008G203
|
3.3% |
7/22/2026
Event 7/20/2026
|
||||
|
Lifeward Ltd.
13D
LFWD · M8216Q309
|
49.9% |
5/14/2026
Event 3/25/2026
|
||||
|
Alpha Tau Medical Ltd.
13D
DRTS · M0740A108
|
20.0% |
5/1/2025
Event 4/24/2025
|
||||
| Oramed Pharmaceuticals Inc. | 20.0% | |||||
| Oramed Ltd. | 20.0% | |||||
| Schedule 13G · 2 securities · passive | ||||||
|
Scilex Holding Co
13G/A
SCLX · 80880W205
|
4.9% |
2/13/2026
Event 12/31/2025
|
||||
|
Scilex Holding Company
13G/A
SCLX · 80880W106
|
9.9% |
5/8/2025
Event 3/31/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.